Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Guelph

$39,000.00

Host-parasite interactions of apicomplexan parasites with their vertebrate hosts

EF 2009-10

Résumé
Many of apicomplexan parasites (such as malaria, Toxoplasma and coccidia) are of serious veterinary, agricultural and medical importance. Eimeria are continuing and serious challenges to profitable rearing of commercial poultry (especially chickens). Medication costs and production losses from coccidiosis cost the poultry industry several $100 million each year in Canada. Live vaccines against coccidia are possible but are complicated by immunologically distinct strains of many Eimeria species and alteration to the intestinal tract that can predispose chickens to bacterial disease (esp. necrotic enteritis). We have distinct lines of E. maxima that are similar to one another but do not cross-immunize birds (they do not protect against challenge with the second strain despite their similarity). The few differences that exist between these E. maxima strains must be important targets of a protective immune response. The strains will continue to be dissected at the molecular level to identify unique molecules in each strain that may represent immunologically important antigens that the chickens use to protect themselves against challenge; this hypothesis will be tested once the unique molecules have been isolated. This is critical for the generation of non-viable vaccines against coccidia. Second, the immune responses of birds will be examined when infected with one strain of the parasite and then challenged with the second strain. To address the limitations of live vaccines in broiler chickens (because of an altered gut environment that promotes serious bacterial enteritis), probiotic bacteria (harmless, beneficial commensal bacteria isolated from chickens) will be tested for their ability to protect the intestinal tract of birds during live coccidial vaccination. If proven, this method could radically reduce our reliance on in-feed drugs currently employed to control these parasites in meat birds. Finally, in other work, we hope to better understand the evolutionary relationships that exist among all parasites of the phylum Apicomplexa. In addition to better understanding our biological world, characterizing poorly known parasites will give us a way to predict likely life cycles, potential hosts and possible drug sensitivities for agents of emerging parasitic disease.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
106453-2007
Name nom
Barta, John
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2007
Award amount
39000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Partie
3
Nb partie
3
Application title
Host-parasite interactions of apicomplexan parasites with their vertebrate hosts
Keyword
NA
Application summary
Many of apicomplexan parasites (such as malaria, Toxoplasma and coccidia) are of serious veterinary, agricultural and medical importance. Eimeria are continuing and serious challenges to profitable rearing of commercial poultry (especially chickens). Medication costs and production losses from coccidiosis cost the poultry industry several $100 million each year in Canada. Live vaccines against coccidia are possible but are complicated by immunologically distinct strains of many Eimeria species and alteration to the intestinal tract that can predispose chickens to bacterial disease (esp. necrotic enteritis). We have distinct lines of E. maxima that are similar to one another but do not cross-immunize birds (they do not protect against challenge with the second strain despite their similarity). The few differences that exist between these E. maxima strains must be important targets of a protective immune response. The strains will continue to be dissected at the molecular level to identify unique molecules in each strain that may represent immunologically important antigens that the chickens use to protect themselves against challenge; this hypothesis will be tested once the unique molecules have been isolated. This is critical for the generation of non-viable vaccines against coccidia. Second, the immune responses of birds will be examined when infected with one strain of the parasite and then challenged with the second strain. To address the limitations of live vaccines in broiler chickens (because of an altered gut environment that promotes serious bacterial enteritis), probiotic bacteria (harmless, beneficial commensal bacteria isolated from chickens) will be tested for their ability to protect the intestinal tract of birds during live coccidial vaccination. If proven, this method could radically reduce our reliance on in-feed drugs currently employed to control these parasites in meat birds. Finally, in other work, we hope to better understand the evolutionary relationships that exist among all parasites of the phylum Apicomplexa. In addition to better understanding our biological world, characterizing poorly known parasites will give us a way to predict likely life cycles, potential hosts and possible drug sensitivities for agents of emerging parasitic disease.